News
Breakthrough Device designation granted by FDA
Injeq IQ-Tip system has been granted the Breakthrough Device designation by FDA! The FDA’s Breakthrough Devices Program is designed to […]
Read more »
Large multicenter trial of pediatric hemato-oncology patients sponsored by Injeq
A clinical investigation conducted in all five Finnish university hospitals and sponsored by Injeq has begun in May. A peer-reviewed […]
Read more »
Tiedote
Injeq on yhdessä Invesdorin kanssa järjestellyt osakeantia, joka käynnistyy ns. ”hiljaisella kierroksella”, jolloin nykyiset omistajat pääsevät merkitsemään osakkeita ensin, jonka […]
Read more »
Injeq’s distributor network is expanding outside Europe
Injeq Plc is proud to introduce Mareen Group, the new distributor of Injeq in the Kuwaiti market. Mareen group, founded […]
Read more »
Injeq introduced to health tech in Hong Kong
Injeq visited Hong Kong as part of the Finnish HealthTech delegation. There were many interesting introductions of business opportunities in […]
Read more »
Injeq participates the Congress of EPNS
The 15th EPNS Congress will take place at the Prague Conference Centre, Prague, Czech Republic […]
Read more »
Injeq participating GNPI 2023, neonatology and pediatric intensive care congress in Hamburg in June
Germany’s 49th Annual Meeting of the Society for Neonatology and Pediatric Intensive Care Medicine will be held in Hamburg from […]
Read more »
Injeq is one of the Europe’s Top 5 Medical Device Companies to Watch in 2023
Healthcare advancements that were mere ideas decades ago are coming to fruition, proving to be much more valuable to saving […]
Read more »
Päivi Lehtonen starting as Injeq’s new Sales Director in April
The current CEO of Teivo, Päivi Lehtonen, will start as Injeq’s new Sales Director in the beginning of April. Päivi […]
Read more »